131 results
Page 2 of 7
S-4/A
EX-10.20
c2rnsv0ys4l17ytmyc
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4/A
hhdushev
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
EX-10.9
j6hj8k0t0r2x y1
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.15
mcqy lnrh9
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-2.5
6qtbtk84b13xahumak
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.17
aycvt wx4tl
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.14
oguhyh4lk5ce2 tx3
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-2.4
unmffxtbeh9
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.11
orlzs 6wyd3sg
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.18
hmhpru6vw42ec d9
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-2.2
r6c4z ptdqnu5q
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-2.3
ys85jvn4zvamrh3kl
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
fojujd0fevi
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.1
7uogbxel786yvhex
19 Jul 22
VBL Therapeutics Announces Top-Line Data from Phase 3 OVAL Trial of Ofra-Vec in Patients with Platinum-Resistant Ovarian Cancer
4:09pm
6-K
EX-99.2
nau6xoy7 8sax1zl
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
S-8
sf0s1vs
31 May 22
Registration of securities for employees
5:16pm
6-K
EX-99.1
oii7xyq0
17 May 22
VBL Therapeutics Reports First Quarter 2022 Financial Results
7:00am
6-K
EX-99.3
hwf1wzz 8xa
17 May 22
VBL Therapeutics Reports First Quarter 2022 Financial Results
7:00am
6-K
EX-99.1
smwicim24zzanv108
26 Apr 22
VBL Therapeutics Receives FDA Fast Track Designation for Ofra-Vec for the Treatment of Platinum-Resistant Ovarian Cancer
8:05am